Results 71 to 80 of about 303,596 (194)
Grave’s Disease in Brazzaville: Clinical Presentation and Diagnosis
RÉSUMÉ Introduction. La maladie de Basedow est une pathologie auto-immune affectant la glande thyroïde, caractérisée par un syndrome de thyrotoxicose associée un goitre diffus et une orbitopathie.
Elilié Mawa Ongoth +10 more
doaj +1 more source
The authors describe a case of bilateral diffuse paraneoplastic orbital myositis induced by a stage IA left testicular pure seminoma. The patient presented with findings typical of thyroid-associated orbitopathy (TAO) and was thought to have TAO until ...
Bernard, Léa +4 more
core +1 more source
Assessing the risks of endocrine-disrupting chemicals
In this chapter, four European regulatory frameworks are compared concerning how they cope with identifying and risk assessing endocrine-disrupting chemicals.
A. Beronius +14 more
core +1 more source
Endocrine disruptors in bottled mineral water : total estrogenic burden and migration from plastic bottles [PDF]
Background, aim, and scope Food consumption is an important route of human exposure to endocrine-disrupting chemicals. So far, this has been demonstrated by exposure modeling or analytical identification of single substances in foodstuff (e.g ...
Jörg Oehlmann +3 more
core +1 more source
Multiple Endocrine Neoplasia Type 1 (MEN1): Loss of One MEN1 Allele in Tumors and Monohormonal Endocrine Cell Clusters But Not in Islet Hyperplasia of the Pancreas [PDF]
CONTEXT: The occurrence of multiple small pancreatic endocrine tumors in patients suffering from multiple endocrine neoplasia type 1 (MEN1) represents a unique possibility to study early neoplasms and their potential precursor lesions.
Thomas Rudolph +38 more
core +2 more sources
Endocrine disruptors and metabolic changes: impact on puberty control
Objective: This study aims to explore the significant impact of environmental chemicals on disease development, focusing on their role in developing metabolic and endocrine diseases.
Lizcano F., Peralta M
core +1 more source
Natural history of graves’ orbitopathy after treatment
Intravenous glucocorticoids are used for Graves’ orbitopathy, alone or associated with/followed by additional treatments (orbital radiotherapy, orbital decompression, palpebral or eye surgery).
SELLARI FRANCESCHINI, STEFANO +9 more
core +1 more source
Patients with symptoms of thyroid-associated orbitopathy are classifi ed on the basis of the clinical activity score (CAS) proposed by Mourits in 1989.
Dorota Walasik-Szemplińska +7 more
core +1 more source
Late reactivation of thyroid orbitopathy
BackgroundThyroid orbitopathy is characterized by spontaneous remissions and exacerbations. Although data on the natural history are scarce, the active phase is usually self-limited, encompassing an average period of 18-36 months.
King, G., Selva-Nayagam, D., Chen, C.
core +1 more source

